{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:12:45Z","timestamp":1795090365179,"version":"4.10.2"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Serum amyloid P component (SAP, also known as Pentraxin 2;\n                    <jats:italic>APCS<\/jats:italic>\n                    gene) is a component of the humoral arm of innate immunity involved in resistance to bacterial infection and regulation of tissue remodeling. Here we investigate the role of SAP in antifungal resistance.\n                    <jats:italic>Apcs<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    mice show enhanced susceptibility to\n                    <jats:italic>A. fumigatus<\/jats:italic>\n                    infection. Murine and human SAP bound conidia, activate the complement cascade and enhance phagocytosis by neutrophils.\n                    <jats:italic>Apcs<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    mice are defective in vivo in terms of recruitment of neutrophils and phagocytosis in the lungs. Opsonic activity of SAP is dependent on the classical pathway of complement activation. In immunosuppressed mice, SAP administration protects hosts against\n                    <jats:italic>A<\/jats:italic>\n                    .\n                    <jats:italic>fumigatus<\/jats:italic>\n                    infection and death. In the context of a study of hematopoietic stem-cell transplantation, genetic variation in the human\n                    <jats:italic>APCS<\/jats:italic>\n                    gene is associated with susceptibility to invasive pulmonary aspergillosis. Thus, SAP is a fluid phase pattern recognition molecule essential for resistance against\n                    <jats:italic>A<\/jats:italic>\n                    .\n                    <jats:italic>fumigatus<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-24021-y","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T06:03:07Z","timestamp":1623996187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Serum amyloid P component is an essential element of resistance against Aspergillus fumigatus"],"prefix":"10.1038","volume":"12","author":[{"given":"Andrea","family":"Doni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3607-1380","authenticated-orcid":false,"given":"Raffaella","family":"Parente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Laface","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Magrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6002-5782","authenticated-orcid":false,"given":"Cristina","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4480-3481","authenticated-orcid":false,"given":"Federico Simone","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o F.","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Ant\u00f3nio","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N.","family":"Mapelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Petroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Porte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilo","family":"Schorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8110-0027","authenticated-orcid":false,"given":"Antonio","family":"Inforzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1517-6426","authenticated-orcid":false,"given":"Toine","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8668-1350","authenticated-orcid":false,"given":"Katrien","family":"Lagrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4257-5980","authenticated-orcid":false,"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Lambris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1930-9257","authenticated-orcid":false,"given":"Barbara","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1510-7703","authenticated-orcid":false,"given":"Cecilia","family":"Garlanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1458-3791","authenticated-orcid":false,"given":"Marina","family":"Botto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8935-8030","authenticated-orcid":false,"given":"Agostinho","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5578-236X","authenticated-orcid":false,"given":"Alberto","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"24021_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-immunol-030409-101305","volume":"28","author":"B Bottazzi","year":"2010","unstructured":"Bottazzi, B., Doni, A., Garlanda, C. & Mantovani, A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Ann. Rev. Immunol. 28, 157\u2013183 (2010).","journal-title":"Ann. Rev. Immunol."},{"key":"24021_CR2","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1152\/physrev.00016.2017","volume":"98","author":"C Garlanda","year":"2018","unstructured":"Garlanda, C., Bottazzi, B., Magrini, E., Inforzato, A. & Mantovani, A. PTX3, a humoral pattern recognition molecule, in innate immunity, tissue repair, and cancer. Physiol. Rev. 98, 623\u2013639 (2018).","journal-title":"Physiol. Rev."},{"key":"24021_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1600-065X.2012.01162.x","volume":"250","author":"J Lu","year":"2012","unstructured":"Lu, J., Marjon, K. D., Mold, C., Du Clos, T. W. & Sun, P. D. Pentraxins and Fc receptors. Immunol. Rev. 250, 230\u2013238 (2012).","journal-title":"Immunol. Rev."},{"key":"24021_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.smim.2018.03.003","volume":"38","author":"MP Reichhardt","year":"2018","unstructured":"Reichhardt, M. P. & Meri, S. Intracellular complement activation-An alarm raising mechanism? Sem. Immunol. 38, 54\u201362 (2018).","journal-title":"Sem. Immunol."},{"key":"24021_CR5","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1002\/1873-3468.12284","volume":"590","author":"S Meri","year":"2016","unstructured":"Meri, S. Self-nonself discrimination by the complement system. FEBS Lett. 590, 2418\u20132434 (2016).","journal-title":"FEBS Lett."},{"key":"24021_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nri.2017.97","volume":"18","author":"ES Reis","year":"2018","unstructured":"Reis, E. S., Mastellos, D. C., Ricklin, D., Mantovani, A. & Lambris, J. D. Complement in cancer: untangling an intricate relationship. Nat. Rev. Immunol. 18, 5\u201318 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"24021_CR7","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI200318921","volume":"111","author":"MB Pepys","year":"2003","unstructured":"Pepys, M. B. & Hirschfield, G. M. C-reactive protein: a critical update. J. Clin. Invest. 111, 1805\u20131812 (2003).","journal-title":"J. Clin. Invest."},{"key":"24021_CR8","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.3389\/fimmu.2018.02382","volume":"9","author":"MB Pepys","year":"2018","unstructured":"Pepys, M. B. The pentraxins 1975-2018: serendipity, diagnostics and drugs. Front. Immunol. 9, 2382 (2018).","journal-title":"Front. Immunol."},{"key":"24021_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/278259a0","volume":"278","author":"MB Pepys","year":"1979","unstructured":"Pepys, M. B., Baltz, M., Gomer, K., Davies, A. J. & Doenhoff, M. Serum amyloid P-component is an acute-phase reactant in the mouse. Nature 278, 259\u2013261 (1979).","journal-title":"Nature"},{"key":"24021_CR10","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.3389\/fimmu.2018.02328","volume":"9","author":"D Pilling","year":"2018","unstructured":"Pilling, D. & Gomer, R. H. The development of serum amyloid P as a possible therapeutic. Front. Immunol. 9, 2328 (2018).","journal-title":"Front. Immunol."},{"key":"24021_CR11","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.jhep.2016.02.029","volume":"64","author":"B Bottazzi","year":"2016","unstructured":"Bottazzi, B. et al. The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling. J. Hepatol. 64, 1416\u20131427 (2016).","journal-title":"J. Hepatol."},{"key":"24021_CR12","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1084\/jem.20141268","volume":"212","author":"A Doni","year":"2015","unstructured":"Doni, A. et al. An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode. J. Exp. Med. 212, 905\u2013925 (2015).","journal-title":"J. Exp. Med."},{"key":"24021_CR13","doi-asserted-by":"crossref","unstructured":"Doni, A., D\u2019Amico, G., Morone, D., Mantovani, A. & Garlanda, C. Humoral innate immunity at the crossroad between microbe and matrix recognition: the role of PTX3 in tissue damage. Sem. Cell Develop. Biol. 61, 31\u201340 (2016).","DOI":"10.1016\/j.semcdb.2016.07.026"},{"key":"24021_CR14","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.smim.2016.10.012","volume":"28","author":"A Doni","year":"2016","unstructured":"Doni, A., Garlanda, C. & Mantovani, A. Innate immunity, hemostasis and matrix remodeling: PTX3 as a link. Sem. Immunol. 28, 570\u2013577 (2016).","journal-title":"Sem. Immunol."},{"key":"24021_CR15","doi-asserted-by":"publisher","first-page":"e59623","DOI":"10.1371\/journal.pone.0059623","volume":"8","author":"ER Job","year":"2013","unstructured":"Job, E. R. et al. Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses. PLoS ONE 8, e59623 (2013).","journal-title":"PLoS ONE"},{"key":"24021_CR16","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1371\/journal.ppat.0030120","volume":"3","author":"J Yuste","year":"2007","unstructured":"Yuste, J., Botto, M., Bottoms, S. E. & Brown, J. S. Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae. PLoS Pathog. 3, 1208\u20131219 (2007).","journal-title":"PLoS Pathog."},{"key":"24021_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.micinf.2005.08.007","volume":"8","author":"PP Singh","year":"2006","unstructured":"Singh, P. P. & Kaur, S. Serum amyloid P-component in murine tuberculosis: induction kinetics and intramacrophage Mycobacterium tuberculosis growth inhibition in vitro. Microbes Infect. 8, 541\u2013551 (2006).","journal-title":"Microbes Infect."},{"key":"24021_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0165-2478(00)00180-2","volume":"72","author":"P Balmer","year":"2000","unstructured":"Balmer, P., McMonagle, F., Alexander, J. & Stephen Phillips, R. Experimental erythrocytic malaria infection induces elevated serum amyloid P production in mice. Immunol. Lett. 72, 147\u2013152 (2000).","journal-title":"Immunol. Lett."},{"key":"24021_CR19","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.3389\/fimmu.2018.02607","volume":"9","author":"J Lu","year":"2018","unstructured":"Lu, J., Mold, C., Du Clos, T. W. & Sun, P. D. Pentraxins and Fc receptor-mediated immune responses. Front. Immunol. 9, 2607 (2018).","journal-title":"Front. Immunol."},{"key":"24021_CR20","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.3389\/fimmu.2018.03046","volume":"9","author":"YJ Ma","year":"2018","unstructured":"Ma, Y. J. & Garred, P. Pentraxins in complement activation and regulation. Front. Immunol. 9, 3046 (2018).","journal-title":"Front. Immunol."},{"key":"24021_CR21","doi-asserted-by":"publisher","first-page":"26950","DOI":"10.1074\/jbc.270.45.26950","volume":"270","author":"P Garcia de Frutos","year":"1995","unstructured":"Garcia de Frutos, P., Hardig, Y. & Dahlback, B. Serum amyloid P component binding to C4b-binding protein. J. Biol. Chem. 270, 26950\u201326955 (1995).","journal-title":"J. Biol. Chem."},{"key":"24021_CR22","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.4049\/jimmunol.166.11.6735","volume":"166","author":"D Bharadwaj","year":"2001","unstructured":"Bharadwaj, D., Mold, C., Markham, E. & Du Clos, T. W. Serum amyloid P component binds to Fc\u03b3 receptors and opsonizes particles for phagocytosis. J. Immunol. 166, 6735\u20136741 (2001).","journal-title":"J. Immunol."},{"key":"24021_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1006\/jaut.2002.0615","volume":"19","author":"C Mold","year":"2002","unstructured":"Mold, C., Baca, R. & Du Clos, T. W. Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fc\u03b3 receptors. J. Autoimmun. 19, 147\u2013154 (2002).","journal-title":"J. Autoimmun."},{"key":"24021_CR24","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.4049\/jimmunol.166.2.1200","volume":"166","author":"C Mold","year":"2001","unstructured":"Mold, C., Gresham, H. D. & Du Clos, T. W. Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc\u03b3Rs. J. Immunol. 166, 1200\u20131205 (2001).","journal-title":"J. Immunol."},{"key":"24021_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-3083.1997.d01-147.x","volume":"46","author":"O Andersen","year":"1997","unstructured":"Andersen, O. et al. Serum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro. Scand. J. Immunol. 46, 331\u2013337 (1997).","journal-title":"Scand. J. Immunol."},{"key":"24021_CR26","doi-asserted-by":"publisher","first-page":"14584","DOI":"10.1073\/pnas.97.26.14584","volume":"97","author":"M Noursadeghi","year":"2000","unstructured":"Noursadeghi, M. et al. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc. Natl Acad. Sci. USA 97, 14584\u201314589 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"24021_CR27","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nm0897-855","volume":"3","author":"M Botto","year":"1997","unstructured":"Botto, M. et al. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nat. Med. 3, 855\u2013859 (1997).","journal-title":"Nat. Med."},{"key":"24021_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nature09494","volume":"468","author":"K Bodin","year":"2010","unstructured":"Bodin, K. et al. Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. Nature 468, 93\u201397 (2010).","journal-title":"Nature"},{"key":"24021_CR29","doi-asserted-by":"crossref","unstructured":"Richards, D. B. et al. Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis. Sci. Trans. Med. 10, eaan3128(2018).","DOI":"10.1126\/scitranslmed.aan3128"},{"key":"24021_CR30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1189\/jlb.1MR0114-068R","volume":"96","author":"N Cox","year":"2014","unstructured":"Cox, N., Pilling, D. & Gomer, R. H. Serum amyloid P: a systemic regulator of the innate immune response. J. Leukoc. Biol. 96, 739\u2013743 (2014).","journal-title":"J. Leukoc. Biol."},{"key":"24021_CR31","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.4049\/jimmunol.171.10.5537","volume":"171","author":"D Pilling","year":"2003","unstructured":"Pilling, D., Buckley, C. D., Salmon, M. & Gomer, R. H. Inhibition of fibrocyte differentiation by serum amyloid P. J. Immunol. 171, 5537\u20135546 (2003).","journal-title":"J. Immunol."},{"key":"24021_CR32","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.4049\/jimmunol.179.6.4035","volume":"179","author":"D Pilling","year":"2007","unstructured":"Pilling, D. et al. Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J. Immunol. 179, 4035\u20134044 (2007).","journal-title":"J. Immunol."},{"key":"24021_CR33","doi-asserted-by":"publisher","first-page":"e93730","DOI":"10.1371\/journal.pone.0093730","volume":"9","author":"D Pilling","year":"2014","unstructured":"Pilling, D. & Gomer, R. H. Persistent lung inflammation and fibrosis in serum amyloid P component (Apcs\u2212\/\u2212) knockout mice. PLoS ONE 9, e93730 (2014).","journal-title":"PLoS ONE"},{"key":"24021_CR34","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.pupt.2013.01.008","volume":"26","author":"MR Dillingh","year":"2013","unstructured":"Dillingh, M. R. et al. Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis. Pulm. Pharmacol. Ther. 26, 672\u2013676 (2013).","journal-title":"Pulm. Pharmacol. Ther."},{"key":"24021_CR35","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1183\/13993003.00850-2015","volume":"47","author":"B van den Blink","year":"2016","unstructured":"van den Blink, B. et al. Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy. Eur. Respir. J. 47, 889\u2013897 (2016).","journal-title":"Eur. Respir. J."},{"key":"24021_CR36","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1001\/jama.2018.6129","volume":"319","author":"G Raghu","year":"2018","unstructured":"Raghu, G. et al. Effect of recombinant human pentraxin 2 vs placebo on change in forced vital capacity in patients with idiopathic pulmonary fibrosis: a randomized clinical trial. JAMA 319, 2299\u20132307 (2018).","journal-title":"JAMA"},{"key":"24021_CR37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S2213-2600(19)30172-9","volume":"7","author":"G Raghu","year":"2019","unstructured":"Raghu, G. et al. Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study. Lancet Respir. Med. 7, 657\u2013664 (2019).","journal-title":"Lancet Respir. Med."},{"key":"24021_CR38","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature01195","volume":"420","author":"C Garlanda","year":"2002","unstructured":"Garlanda, C. et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 420, 182\u2013186 (2002).","journal-title":"Nature"},{"key":"24021_CR39","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/sj.gene.6364410","volume":"8","author":"R Olesen","year":"2007","unstructured":"Olesen, R. et al. DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun. 8, 456\u2013467 (2007).","journal-title":"Genes Immun."},{"key":"24021_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa1211161","volume":"370","author":"C Cunha","year":"2014","unstructured":"Cunha, C. et al. Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. N. Engl. J. Med. 370, 421\u2013432 (2014).","journal-title":"N. Engl. J. Med."},{"key":"24021_CR41","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1093\/cid\/civ679","volume":"61","author":"C Cunha","year":"2015","unstructured":"Cunha, C. et al. PTX3-based genetic testing for risk of aspergillosis after lung transplant. Clin. Infect. Dis. 61, 1893\u20131894 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"24021_CR42","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/cid\/civ386","volume":"61","author":"A Wojtowicz","year":"2015","unstructured":"Wojtowicz, A. et al. PTX3 polymorphisms and invasive mold infections after solid organ transplant. Clin. Infect. Dis. 61, 619\u2013622 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"24021_CR43","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1182\/blood-2016-10-743294","volume":"129","author":"CE Fisher","year":"2017","unstructured":"Fisher, C. E. et al. Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation. Blood 129, 2693\u20132701 (2017).","journal-title":"Blood"},{"key":"24021_CR44","doi-asserted-by":"crossref","unstructured":"Herrero-Sanchez, M. C. et al. Polymorphisms in receptors involved in opsonic and nonopsonic phagocytosis, and correlation with risk of infection in oncohematology patients. Infect. Immun. 86, e00709\u2013e00718 (2018).","DOI":"10.1128\/IAI.00709-18"},{"key":"24021_CR45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-immunol-042617-053318","volume":"36","author":"MS Lionakis","year":"2018","unstructured":"Lionakis, M. S. & Levitz, S. M. Host control of fungal infections: lessons from basic studies and human cohorts. Ann. Rev. Immunol. 36, 157\u2013191 (2018).","journal-title":"Ann. Rev. Immunol."},{"key":"24021_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fimmu.2019.00088","volume":"10","author":"CF Campos","year":"2019","unstructured":"Campos, C. F. et al. PTX3 polymorphisms influence cytomegalovirus reactivation after stem-cell transplantation. Front. Immunol. 10, 88 (2019).","journal-title":"Front. Immunol."},{"key":"24021_CR47","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/cid\/cix749","volume":"66","author":"Q He","year":"2018","unstructured":"He, Q. et al. Pentraxin 3 gene polymorphisms and pulmonary aspergillosis in chronic obstructive pulmonary disease patients. Clin. Infect. Dis. 66, 261\u2013267 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"24021_CR48","doi-asserted-by":"publisher","first-page":"E243","DOI":"10.1371\/journal.pbio.0020243","volume":"2","author":"AE Bygrave","year":"2004","unstructured":"Bygrave, A. E. et al. Spontaneous autoimmunity in 129 and C57BL\/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2, E243 (2004).","journal-title":"PLoS Biol."},{"key":"24021_CR49","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40588-018-0098-6","volume":"5","author":"JV Desai","year":"2018","unstructured":"Desai, J. V. & Lionakis, M. S. The role of neutrophils in host defense against invasive fungal infections. Curr. Clin. Microbiol. Rep. 5, 181\u2013189 (2018).","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"24021_CR50","doi-asserted-by":"publisher","first-page":"45720","DOI":"10.1074\/jbc.M303704200","volume":"278","author":"J Jongstra-Bilen","year":"2003","unstructured":"Jongstra-Bilen, J., Harrison, R. & Grinstein, S. Fc\u03b3-receptors induce Mac-1 (CD11b\/CD18) mobilization and accumulation in the phagocytic cup for optimal phagocytosis. J. Biol. Chem. 278, 45720\u201345729 (2003).","journal-title":"J. Biol. Chem."},{"key":"24021_CR51","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1182\/blood-2009-12-258376","volume":"116","author":"F Moalli","year":"2010","unstructured":"Moalli, F. et al. Role of complement and Fc\u03b3 receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood 116, 5170\u20135180 (2010).","journal-title":"Blood"},{"key":"24021_CR52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fimmu.2016.00473","volume":"7","author":"A Rosbjerg","year":"2016","unstructured":"Rosbjerg, A. et al. Complementary roles of the classical and lectin complement pathways in the defense against Aspergillus fumigatus. Front. Immunol. 7, 473 (2016).","journal-title":"Front. Immunol."},{"key":"24021_CR53","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.3389\/fmicb.2017.02362","volume":"8","author":"SM Goncalves","year":"2017","unstructured":"Goncalves, S. M. et al. Evaluation of bronchoalveolar lavage fluid cytokines as biomarkers for invasive pulmonary aspergillosis in at-risk patients. Front. Microbiol. 8, 2362 (2017).","journal-title":"Front. Microbiol."},{"key":"24021_CR54","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.0300-9475.2004.01412.x","volume":"59","author":"S Kaur","year":"2004","unstructured":"Kaur, S. & Singh, P. P. Serum amyloid P-component-mediated inhibition of the uptake of Mycobacterium tuberculosis by macrophages, in vitro. Scand. J. Immunol. 59, 425\u2013431 (2004).","journal-title":"Scand. J. Immunol."},{"key":"24021_CR55","doi-asserted-by":"crossref","unstructured":"Behrens, N. E., Lipke, P. N., Pilling, D., Gomer, R. H. & Klotz, S. A. Serum amyloid P component binds fungal surface amyloid and decreases human macrophage phagocytosis and secretion of inflammatory cytokines. MBio 10, e00218\u2013e00219 (2019).","DOI":"10.1128\/mBio.00218-19"},{"key":"24021_CR56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2010.01.046","volume":"211","author":"Z Song","year":"2010","unstructured":"Song, Z. et al. Accumulation and expression of serum amyloid P component in human atherosclerotic lesions. Atherosclerosis 211, 90\u201395 (2010).","journal-title":"Atherosclerosis"},{"key":"24021_CR57","doi-asserted-by":"crossref","unstructured":"Brunetta, E. et al. Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19. Nat. Immunol. 22, 19\u201324 (2020).","DOI":"10.1038\/s41590-020-00832-x"},{"key":"24021_CR58","doi-asserted-by":"publisher","first-page":"5394","DOI":"10.1182\/blood-2010-04-279307","volume":"116","author":"C Cunha","year":"2010","unstructured":"Cunha, C. et al. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. Blood 116, 5394\u20135402 (2010).","journal-title":"Blood"},{"key":"24021_CR59","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/hmg\/ddi051","volume":"14","author":"ML Soares","year":"2005","unstructured":"Soares, M. L. et al. Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease. Hum. Mol. Genet. 14, 543\u2013553 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"24021_CR60","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw, B. et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin. Infect. Dis. 46, 1813\u20131821 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"24021_CR61","doi-asserted-by":"crossref","unstructured":"Santus, W. et al. Skin infections are eliminated by cooperation of the fibrinolytic and innate immune systems. Sci. Immunol. 2, eaan2725 (2017).","DOI":"10.1126\/sciimmunol.aan2725"},{"key":"24021_CR62","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1182\/blood-2013-02-485771","volume":"123","author":"N Rapin","year":"2014","unstructured":"Rapin, N. et al. Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients. Blood 123, 894\u2013904 (2014).","journal-title":"Blood"},{"key":"24021_CR63","doi-asserted-by":"publisher","first-page":"e0164985","DOI":"10.1371\/journal.pone.0164985","volume":"11","author":"JB Svendsen","year":"2016","unstructured":"Svendsen, J. B. et al. MicroRNA-941 expression in polymorphonuclear granulocytes is not related to granulomatosis with polyangiitis. PLoS ONE 11, e0164985 (2016).","journal-title":"PLoS ONE"},{"key":"24021_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-9-302","volume":"9","author":"S Maouche","year":"2008","unstructured":"Maouche, S. et al. Performance comparison of two microarray platforms to assess differential gene expression in human monocyte and macrophage cells. BMC Genomics 9, 302 (2008).","journal-title":"BMC Genomics"},{"key":"24021_CR65","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s00134-007-0748-2","volume":"33","author":"E Silva","year":"2007","unstructured":"Silva, E. et al. HMGB1 and LPS induce distinct patterns of gene expression and activation in neutrophils from patients with sepsis-induced acute lung injury. Intensive Care Med. 33, 1829\u20131839 (2007).","journal-title":"Intensive Care Med."},{"key":"24021_CR66","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/nm1303","volume":"11","author":"JW Tyner","year":"2005","unstructured":"Tyner, J. W. et al. CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat. Med. 11, 1180\u20131187 (2005).","journal-title":"Nat. Med."},{"key":"24021_CR67","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/ni.1976","volume":"12","author":"LC Hsu","year":"2011","unstructured":"Hsu, L. C. et al. IL-1\u03b2-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKK \u03b2. Nat. Immunol. 12, 144\u2013150 (2011).","journal-title":"Nat. Immunol."},{"key":"24021_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24021-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24021-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24021-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T08:06:59Z","timestamp":1669968419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24021-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["24021"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-24021-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"21 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.M. and A.D. are inventors of a patent on SAP (WO2020127471). The other authors do not report competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3739"}}